Acta Neurologica Scandinavica

Papers
(The H4-Index of Acta Neurologica Scandinavica is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
123
57
Issue Information54
Issue Information52
Awake Surgery for Tumors of the Parietal Lobe: A Preliminary Experience with a New Protocol of Intraoperative Neuropsychological Test for the Monitoring of the Sensory Area Function48
Drug‐Induced Intracranial Pressure Increase: Disproportionality Analysis of the Public Version of the FDA Event Reporting System42
Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CA40
Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County35
Characteristics of sagittal spinopelvic alignment in patients with Parkinson's disease34
The prognosis of late‐onset anti‐N‐methyl‐D‐aspartate receptor encephalitis in China32
Validity and reliability characteristics of the Silhouettes Fatigue Scale in measuring multiple sclerosis‐related fatigue in Turkish‐speaking adults31
Quality of life in patients with glioblastoma and their relatives29
The Diagnostic Pathway for Intracranial Tumours: A 10‐Year North Denmark Region Cohort Study29
Epileptic seizure control during and after pregnancy in Australian women28
Diplopia in Parkinson's disease: Indication of a cortical phenotype with cognitive dysfunction?26
Blood based biomarkers for movement disorders26
Fatigue and Sleepiness in Multiple Sclerosis and Their Response to Short‐Term Treatment With Modafinil25
Etiologies of Rapidly Progressive Dementia: A Cross‐Sectional Multicentric Tertiary Hospital Study23
Effects of fast‐velocity concentric resistance training in people with multiple sclerosis: A randomized controlled trial23
Systolic blood pressure variability following endovascular thrombectomy and clinical outcome in acute ischemic stroke: A meta‐analysis22
Medium‐term changes in patients with epilepsy during the COVID‐19 pandemic22
Tocilizumab for severe refractory primary central nervous system vasculitis: A center experience22
0.071521997451782